Technical analysis of Crinetics Pharmaceuticals, Inc. (CRNX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Crinetics Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical enterprise, dedicated to the identification, advancement, and market introduction of therapeutic solutions for infrequent endocrine conditions and related tumors. Their flagship drug candidate, Paltusotine, is an orally administered, selective, non-peptide somatostatin receptor type 2 agonist.
Price
| Price | $84.95 |
| Market Cap | $9.0B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 7.52 |
| EV / EBITDA | -17.68 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.04 |
| Current Ratio | 15.57 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 16.09 |
Explore sector: Healthcare · Biotechnology
More sections of CRNX: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks